Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT02107105
- Status
- Recruiting
Conditions
- Rectal Adenocarcinoma
- Stage I Rectal Cancer AJCC v8
- Stage II Rectal Cancer AJCC v8
- Stage IIA Rectal Cancer AJCC v8
- Stage IIB Rectal Cancer AJCC v8
- Stage IIC Rectal Cancer AJCC v8
- Stage III Rectal Cancer AJCC v8
- Stage IIIA Rectal Cancer AJCC v8
- Stage IIIB Rectal Cancer AJCC v8
- Stage IIIC Rectal Cancer AJCC v8
- Stage IV Rectal Cancer AJCC v8
- Stage IVA Rectal Cancer AJCC v8
- Stage IVB Rectal Cancer AJCC v8
- Stage IVC Rectal Cancer AJCC v8
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Quality-of-Life Assessment — OTHERComplete quality of life questionnaire
- Questionnaire Administration — OTHERComplete quality of life questionnaire
Study Details
This study evaluates quality of life and utilities following surgical treatment of stage I-IV rectal cancer. This study may help researches learn more about quality of life in patients who have or have had rectal cancer.
Key Dates
- Start date
- May 16, 2014
- Status verified
- Mar 2026
- Primary completion
- May 31, 2030
- Completion
- May 31, 2030
Study Design
- Enrollment
- 430 participants (estimated)
Arms
- Arm: Observational (questionnaire)Patients complete quality of life questionnaires over 20-30 minutes at baseline, 6 and 12 months after surgery, and 2, 3, 4, and 5 years after surgery.
Primary Outcome Measure
Health state utilities [ Time Frame: At 24 months post-surgery ]
Central Contacts
- George Chang713-792-6940
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| M D Anderson Cancer Center | Houston | Texas | 77030 | George J. Chang 713-792-6940 George J. Chang (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By research site
Related Studies
- Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal CancerEARLY_PHASE1 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas
- ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationRecruiting · Guardant Health, Inc. · Birmingham, Alabama
- Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant TherapyPHASE2 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas
- A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)PHASE3 · Recruiting · Merck Sharp & Dohme LLC · Los Angeles, California